Retatrutide
Triple-receptor agonist explored for next-generation weight management research.
About:
Retatrutide is a triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways simultaneously. It represents a newer direction in metabolic peptide research aimed at amplifying weight-management effects.
What does this peptide do?
Early studies investigate how engaging three receptors influences fat loss and energy expenditure compared with established GLP-1 therapies. The molecule is a frequent point of comparison in fat-loss research.
Weight research
Phase 2 trials examine fat loss and energy expenditure.
Metabolic pathways
Engages GIP, GLP-1 and glucagon receptors at once.
Evidence grade
AHighest evidence grade among the graded claims: A. Grades reflect study strength, not benefit.
What are the benefits and side effects of this peptide
What research says it may help with
- Retatrutide has been tested in phase 2 randomized trials, not yet phase 3.
- Trials in adults with obesity reported dose-dependent weight reductions over 48 weeks.
- Long-term and broader safety data remain unavailable.
Who should avoid it
- People who are pregnant
- People who are breastfeeding
- Children and adolescents
- People with unmonitored diabetes
- People with a history of thyroid C-cell tumors
See the safety section. Absence of a flag is not evidence of safety.
A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.
How to store this peptide
Retatrutide is typically handled as a peptide requiring refrigerated storage before use, with protection from light and heat. Reconstituted or drawn doses are treated as single-use and require sterile technique to avoid contamination. Any change in color, clarity, or particulate matter should be treated as a reason to discard the material.
Lyophilized storage
Store at −20 °C, protected from light.
Reconstituted storage
Keep at 2–8 °C and use within a short period. For longer storage, aliquot and freeze at −20 °C.
Storage Handling
Avoid repeated freeze–thaw cycles. Let the vial reach room temperature before opening.
Draw the exact dose, every time
Related research
Related peptides
MetabolicTirzepatide
Dual GIP/GLP-1 receptor agonist studied for weight management and glucose control.
MetabolicSemaglutide
GLP-1 receptor agonist researched for appetite regulation and metabolic health.
MetabolicAICAR
AICAR is one of the most used laboratory activators of AMPK, and that identity is well documented in a systematic review. Disease model evidence,...